The medicines regulator, Swissmedic, has given the go ahead to the one-shot vaccine from the US company Johnson and Johnson.
Sometimes known as the Janssen Vaccine, it has a 66.9% efficacy rate in those over 18 years old.
The drug was put forward for authorisation in December.
The vaccine has been used in the United States since February.
As yet, there’s no information when it will start to be used.
G7 underway in Evian
The G7 summit opened in Évian yesterday with the possible peace deal between Iran and the US pushed to the top of the agenda.
Parliament wants funding details on nuclear power
The lower house of parliament, the National Council, has declined to lift the ban on building new nuclear plants, sending the proposal back to the Federal Council for financing clarification.
Police criticised after G7 protests
Political fallout continues from Sunday's anti-G7 protests in Geneva.
Bern clears path for Geneva for more parental leave
The upper house of Parliament in Bern has cleared the way for Geneva to introduce a 24-week parental leave, lifting the federal opposition that had blocked the cantonal scheme for nearly two years.
Geneva communes fight swimsuit law
Four more Geneva communes — Meyrin, Carouge, Lancy and the City of Geneva - have filed a legal challenge against the canton's new swimsuit law.
Online shopping driving many to debt
We’re spending more than we can afford, mainly due to online shopping and ‘buy now, pay later’ offers.
